BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10420532)

  • 1. [Rectal carcinoma. Optimizing treatment by neoadjuvant and adjuvant therapy?].
    Fasolini F
    Zentralbl Chir; 1999; 124(5):441-5. PubMed ID: 10420532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant radiochemotherapy for rectal cancer].
    Zehentmayr F; Wolf M; Weissenborn Y; Feldmann HJ; Belka C
    MMW Fortschr Med; 2011 Sep; 153(35):31-3. PubMed ID: 21916302
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications.
    Ratto C; Ricci R; Valentini V; Castri F; Parello A; Gambacorta MA; Cellini N; Vecchio FM; Doglietto GB
    Ann Surg Oncol; 2006 Nov; 13(11):1393-402. PubMed ID: 17013687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant combined radiochemotherapy of rectum carcinoma with long-term 5-fluorouracil infusion].
    Fischbach W
    Z Gastroenterol; 1997 Mar; 35(3):227-8. PubMed ID: 9173691
    [No Abstract]   [Full Text] [Related]  

  • 7. The multidisciplinary management of rectal cancer.
    Meredith KL; Hoffe SE; Shibata D
    Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rectal carcinoma--oncologically adequate resection].
    Simon D
    Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of local surgical therapy for rectal cancer. A literature analysis].
    Borschitz T; Junginger T
    Zentralbl Chir; 2003 Dec; 128(12):1066-74. PubMed ID: 14750068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitation of surgical radicality in rectal cancer responding to neoadjuvant therapy.
    Troja A; Hempen HG; Raab HR
    Onkologie; 2009 May; 32(5):286-90. PubMed ID: 19420978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Total mesorectal excison and colonic-J-pouch-anal anastomosis in the therapy of low rectal carcinoma--results in 116 patients].
    Ommer A; Girona-Johannkemper M; Jung KP; Berg E
    Zentralbl Chir; 2002 Sep; 127(9):775-80. PubMed ID: 12221559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision.
    Colquhoun P; Wexner SD; Cohen A
    J Surg Oncol; 2003 Jul; 83(3):133-9. PubMed ID: 12827680
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant therapy of rectal cancer].
    Bouaouina N; Boussen H
    Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.